Steris | STE - Current Assets


Steris reported $2.48B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
3M USD 16.71B 2.6B Sep/2026
Accuray USD 292.39M 11.22M Dec/2025
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Boston Scientific USD 8.16B 192M Sep/2026
CONMED USD 682.04M 6.37M Sep/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dexcom USD 3.92B 170.6M Sep/2026
Ecolab USD 7.1B 3.92B Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Fortive USD 1.58B 19M Sep/2026
Getinge SEK 15.77B 2.39B Jun/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Haemonetics USD 855.53M 44.7M Sep/2026
Idexx Laboratories USD 1.5B 9.48M Sep/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Olympus JPY 652.66B 15.18B Sep/2026
Orthofix International USD 430.79M 15.34M Sep/2026
Owens Minor USD 273.92M 2.47M Sep/2026
ResMed USD 3.51B 815.82M Sep/2026
Steris USD 2.48B 33.4M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Tandem Diabetes Care USD 820.72M 16.08M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026